“…Further, there is ongoing research on potential effects of specific drug substances on cognitive performance [14]. To date, several studies focused on pediatric populations [12,[15][16][17], but there is a significant need for investigating the cognitive profile of children with new-onset epilepsy prior to initiation of drug treatment to control for the potential effect of Epilepsy & Behavior 60 (2016) 42-49 medication [18]. Additionally, recent studies point to a heightened prevalence of cognitive deficits in adults as well as in children with newonset epilepsy in the early phase of illness, i.e., before treatment is started or even prior to seizures [4,11,[19][20][21].…”